Skorpios Trust Stoke Therapeutics, Inc. Transaction History
Skorpios Trust
- $110 Million
- Q3 2024
A detailed history of Skorpios Trust transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, Skorpios Trust holds 8,906,181 shares of STOK stock, worth $101 Million. This represents 99.85% of its overall portfolio holdings.
Number of Shares
8,906,181
Previous 10,843,681
17.87%
Holding current value
$101 Million
Previous $146 Million
25.28%
% of portfolio
99.85%
Previous 99.89%
Shares
3 transactions
Others Institutions Holding STOK
# of Institutions
124Shares Held
57.6MCall Options Held
9.3KPut Options Held
35.2K-
Black Rock Inc. New York, NY5.41MShares$61.2 Million0.0% of portfolio
-
Lynx1 Capital Management LP San Juan, PR5.19MShares$58.7 Million22.82% of portfolio
-
Redmile Group, LLC San Francisco, CA4.71MShares$53.4 Million3.79% of portfolio
-
Rtw Investments, LP New York, NY4.65MShares$52.7 Million0.91% of portfolio
-
Baker Bros. Advisors LP New York, NY4.37MShares$49.5 Million0.57% of portfolio
About Stoke Therapeutics, Inc.
- Ticker STOK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,419,300
- Market Cap $446M
- Description
- Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...